Integrated DNA Technologies (IDT) has expanded its manufacturing capabilities to Singapore. IDT is now able to provide locally-manufactured oligonucleotides to researchers in Singapore and throughout the region from the company’s first synthesis facility in Asia.
In January of 2012, IDT acquired the oligo business of Singapore’s top supplier, 1st BASE Pte Ltd. Shortly thereafter, IDT began work to create a state-of-the art hub for oligo manufacturing and support dedicated to the Asian market. IDT completed the nearly SGD 6 million project in spring of 2013, and the Singapore company’s synthesis and other processes are now fully integrated with IDT’s operations in the US and Europe.
IDT’s investment in Singapore means that researchers throughout the region can now enjoy quicker delivery of the same high quality custom nucleic acid products they expect from IDT. Through its Asian network of highly skilled sales professionals and 21 appointed distributors, IDT now serves Malaysia, Indonesia, Thailand, Taiwan, the Philippines, Vietnam, Bangladesh, Hong Kong, Nepal, Sri Lanka, and Myanmar from its Singapore company. In the coming months, IDT will expand the services it offers from Singapore to include all the Asia Pacific region’s major markets.
“Our new synthesis and support capabilities in Singapore increase the speed with which we can deliver IDT products to our customers in Asia by 2-3 days,” noted Trey Martin, Chief Operating Officer at IDT.
Said Dr Joseph A. Walder, Founder and CEO of IDT, “Our team in Asia now has a world-class facility in Singapore, with the support of IDT’s global infrastructure backing it up. We’re proud today to offer its benefits to the scientific community in Asia.”
To celebrate, IDT will host an opening ceremony on Wednesday, 24 July from 4 pm to 6 pm. The event will include facility tours, networking, and presentations by IDT’s leadership. The presentations will highlight IDT’s latest innovations in support of synthetic biology, next generation sequencing, and quantitative PCR applications.